# Philips Tops European Patent Rankings in Medtech, Secures No.1 Position at EPO

> Royal Philips has ranked No.1 among medical technology companies in the European Patent Office’s (EPO) 2025 Technology Dashboard. The company filed 676 medtech patent applications in 2025 alone. AI-driven innovation continues to power its strong pipeline in health technology.

Published: 2026-03-30T13:44:00+00:00
Language: en
Categories: [Pharmaceutical Industry](https://chemexworld.com/en/categories/sectors/pharmaceutical-industry-1.md)

Canonical URL:
https://chemexworld.com/en/news/philips-tops-european-patent-rankings-in-medtech-secures-no1-position-at-epo

## Content

Royal Philips, a global leader in health technology, has secured the **top position in medical technology** in the European Patent Office’s (EPO) 2025 Technology Dashboard. The ranking highlights the company’s continued leadership in healthcare innovation.

In 2025, Philips filed **676 medical technology patent applications** with the EPO, including a significant number focused on artificial intelligence (AI). This reflects the company’s strong innovation pipeline centered on data-driven and platform-based health solutions.

Marnix van Ginneken, Member of the Board of Management at Royal Philips, emphasized that the company’s success as a leading EPO applicant demonstrates the strength of its innovation engine and its commitment to meaningful innovation in healthcare and self-care. He noted that Philips’ strategy is powered by **data, AI, and platform-based solutions** to deliver better care to more people.

Philips’ innovations improved the lives of **2 billion people in 2025**. The company aims to reach **2.5 billion people annually by 2030**, including **400 million individuals in underserved communities**.

Recent innovations from Philips include:

- **Helium-free 3.0T MRI technology**, enabling more sustainable and precise diagnostic imaging.

- **Verida spectral CT system and Rembra CT**, delivering faster and more accurate diagnostic insights.

- **LumiGuide 3D Device Guidance**, the first real-time, AI-enabled light-based 3D navigation solution for image-guided therapy.

- **ECG AI Marketplace**, providing cardiac care teams with access to multiple AI-powered diagnostic tools.

- Consumer innovations such as the **AI-powered i9000 Shaver Series**, **Philips Lumea IPL**, and the **Avent Hands-Free Breast Pump**.

Overall, Philips submitted **1,289 European patent applications** across multiple domains, maintaining its position as the largest Dutch applicant. The company was also named a **Clarivate Top 100 Global Innovator for the 13th consecutive year** and invested **over 9% of its revenue in R&D in 2025**, setting a benchmark in the industry.

## Source

[LinkedIn](https://www.linkedin.com/posts/pharmaceutical-business-review-international-a7b54bb5_medtech-europeanpatentoffice-epo-activity-7442136786811637760-7r__?utm_source=share&utm_medium=member_desktop&rcm=ACoAADwxKLABsuNx9uTbGidOC5Vr-C22H_buZIw)